Journal article
β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells
Cancer research (Chicago, Ill.), Vol.75(4), pp.656-665
02/15/2015
DOI: 10.1158/0008-5472.CAN-14-2377
PMCID: PMC4333068
PMID: 25568183
Abstract
Tumors actively suppress antitumor immunity, creating formidable barriers to successful cancer immunotherapy. The molecular mechanisms underlying tumor-induced immune tolerance are largely unknown. In the present study, we show that dendritic cells (DC) in the tumor microenvironment acquire the ability to metabolize vitamin A to produce retinoic acid (RA), which drives regulatory T-cell responses and immune tolerance. Tolerogenic responses were dependent on induction of vitamin A-metabolizing enzymes via the β-catenin/T-cell factor (TCF) pathway in DCs. Consistent with this observation, DC-specific deletion of β-catenin in mice markedly reduced regulatory T-cell responses and delayed melanoma growth. Pharmacologic inhibition of either vitamin A-metabolizing enzymes or the β-catenin/TCF4 pathway in vivo had similar effects on tumor growth and regulatory T-cell responses. Hence, β-catenin/TCF4 signaling induces local regulatory DC and regulatory T-cell phenotypes via the RA pathway, identifying this pathway as an important target for anticancer immunotherapy.
Details
- Title: Subtitle
- β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells
- Creators
- Yuan Hong - Cancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Georgia Regents University, Augusta, Georgia, USAIndumathi Manoharan - Cancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Georgia Regents University, Augusta, Georgia, USAAmol Suryawanshi - Cancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Georgia Regents University, Augusta, Georgia, USATanmay Majumdar - Cancer Immunology, Inflammation, and Tolerance Program, GRU Cancer Center, Georgia Regents University, Augusta, Georgia, USAMelinda L Angus-Hill - Hunstman Cancer Institute, University of Utah, Salt Lake City, UT, USAPandelakis A Koni - Department of Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, USABalaji Manicassamy - Department of Microbiology, University of Chicago, Chicago,IL, USAAndrew L Mellor - Department of Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, USADavid H Munn - Department of Pediatrics, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, USASanthakumar Manicassamy - Department of Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, USA
- Resource Type
- Journal article
- Publication Details
- Cancer research (Chicago, Ill.), Vol.75(4), pp.656-665
- DOI
- 10.1158/0008-5472.CAN-14-2377
- PMID
- 25568183
- PMCID
- PMC4333068
- NLM abbreviation
- Cancer Res
- ISSN
- 0008-5472
- eISSN
- 1538-7445
- Grant note
- R01 CA103320 / NCI NIH HHS R01 DK097271 / NIDDK NIH HHS DK097271 / NIDDK NIH HHS R56 AI104875 / NIAID NIH HHS UL1 TR000430 / NCATS NIH HHS AI04875 / NIAID NIH HHS R01 CA096651 / NCI NIH HHS R01 CA112431 / NCI NIH HHS
- Language
- English
- Date published
- 02/15/2015
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9984083283302771
Metrics
11 Record Views